Hypertension Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Hypertension stocks.

Hypertension Stocks Recent News

Date Stock Title
May 20 BMY Bristol-Myers Squibb: A Safe Haven In Times Of Uncertainty
May 20 LLY Dow Jones Futures: Market Extends Losing Streak, Tesla Breaks Down; What You Must Do Now
May 20 SNY Sanofi Receives Another Approval for Blockbuster Drug Dupixent
May 20 BMY Bristol-Myers Squibb's azacitidine granted additional indication for juvenile leukemia
May 20 LLY Eli Lilly's new diabetes drug Mounjaro priced below Novo Nordisk's Wegovy
May 20 LLY S&P 500 Falls For 7th Consecutive Week Amid Ongoing Inflation, Federal Reserve Rate Hike Fears
May 20 SNY FDA Approves Regeneron and Sanofi's Dupixent (dupilumab) For Eosinophilic Esophagitis (EoE) Ahead of Schedule
May 20 SNY Sanofi wins FDA label expansion for Dupixent for new inflammatory condition
May 20 SNY FDA Approves Dupixent® (dupilumab) as First Treatment for Adults and Children Aged 12 and Older with Eosinophilic Esophagitis
May 20 SNY Press Release: FDA approves Dupixent® (dupilumab) as first treatment for adults and children aged 12 and older with eosinophilic esophagitis
May 20 LLY CHMP Backs Approval of Lilly/Incyte's Olumiant For Patchy Hair Loss
May 20 SNY UPDATE 2-Sanofi's Dupixent wins U.S. approval for bigger use
May 20 BMY Mirati (MRTX) Seeks EU Nod for Adagrasib to Treat Lung Cancer
May 20 LLY Eli Lilly Gets Positive Opinion for Olumiant in Europe. The Stock Rises.
May 20 GILD Top Research Reports for JPMorgan, Gilead Sciences & CSX
May 20 ALKS Radius (RDUS), Menarini Post Positive Data on Breast Cancer Drug
May 20 LLY Radius (RDUS), Menarini Post Positive Data on Breast Cancer Drug
May 20 ALKS LabCorp (LH) Introduces Latest Assay for Skin Cancer Patients
May 20 GILD Gilead at Forefront of Herculean Effort to Combat COVID-19
May 20 LLY Lilly, Incyte's Olumiant get EMA panel nod for hair loss disorder alopecia areata

Hypertension (HTN or HT), also known as high blood pressure (HBP), is a long-term medical condition in which the blood pressure in the arteries is persistently elevated. High blood pressure typically does not cause symptoms. Long-term high blood pressure, however, is a major risk factor for coronary artery disease, stroke, heart failure, atrial fibrillation, peripheral vascular disease, vision loss, chronic kidney disease, and dementia.High blood pressure is classified as either primary (essential) high blood pressure or secondary high blood pressure. About 90–95% of cases are primary, defined as high blood pressure due to nonspecific lifestyle and genetic factors. Lifestyle factors that increase the risk include excess salt in the diet, excess body weight, smoking, and alcohol use. The remaining 5–10% of cases are categorized as secondary high blood pressure, defined as high blood pressure due to an identifiable cause, such as chronic kidney disease, narrowing of the kidney arteries, an endocrine disorder, or the use of birth control pills.Blood pressure is expressed by two measurements, the systolic and diastolic pressures, which are the maximum and minimum pressures, respectively. For most adults, normal blood pressure at rest is within the range of 100–130 millimeters mercury (mmHg) systolic and 60–80 mmHg diastolic. For most adults, high blood pressure is present if the resting blood pressure is persistently at or above 130/80 or 140/90 mmHg. Different numbers apply to children. Ambulatory blood pressure monitoring over a 24-hour period appears more accurate than office-based blood pressure measurement.Lifestyle changes and medications can lower blood pressure and decrease the risk of health complications. Lifestyle changes include weight loss, physical exercise, decreased salt intake, reducing alcohol intake, and a healthy diet. If lifestyle changes are not sufficient then blood pressure medications are used. Up to three medications can control blood pressure in 90% of people. The treatment of moderately high arterial blood pressure (defined as >160/100 mmHg) with medications is associated with an improved life expectancy. The effect of treatment of blood pressure between 130/80 mmHg and 160/100 mmHg is less clear, with some reviews finding benefit and others finding unclear benefit. High blood pressure affects between 16 and 37% of the population globally. In 2010 hypertension was believed to have been a factor in 18% of all deaths (9.4 million globally).

More about Hypertension
Browse All Tags